BioAtla Income Statement (2020-2025) | BCAB

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
0.25M11.00M2.00M
Operating items
Research & Development (Quarter)
10.42M14.85M16.55M16.45M16.92M20.71M19.84M21.87M21.70M30.96M28.40M22.67M18.85M16.20M16.39M11.65M12.36M13.68M9.54M8.00M
Selling, General & Administrative (Quarter)
8.37M15.86M7.14M7.04M7.42M8.34M6.34M6.69M7.23M6.24M6.62M5.86M5.61M5.77M5.88M4.59M5.26M4.96M4.25M3.26M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
18.80M30.71M23.70M23.49M24.35M29.05M26.18M28.56M28.93M37.20M35.02M28.54M24.46M21.97M22.27M16.24M17.61M18.65M13.79M11.26M
Operating Income (Quarter)
-18.80M-30.46M-23.70M-23.49M-24.35M-29.05M-26.18M-28.56M-28.93M-37.20M-35.02M-28.54M-24.46M-21.97M-11.27M-16.24M-17.61M-18.65M-13.79M-9.26M
EBIT (Quarter)
-18.80M-30.46M-23.70M-23.49M-24.35M-29.05M-26.18M-28.56M-28.93M-37.20M-35.02M-28.54M-24.46M-21.97M-11.27M-16.24M-17.61M-18.65M-13.79M-9.26M
Non-operating items
Interest & Investment Income (Quarter)
0.10M0.08M0.08M0.10M0.09M0.15M0.37M1.05M1.48M1.46M1.73M1.64M1.22M0.90M0.69M0.55M0.40M0.23M0.13M0.07M
Other Non Operating Income (Quarter)
0.10M0.08M0.77M-0.25M0.09M0.15M0.40M1.02M1.47M1.45M1.70M1.61M1.22M0.90M0.68M1.36M2.28M-0.06M-1.99M-0.53M
Non Operating Income (Quarter)
0.10M0.08M-0.00M1.04M0.01M0.00M0.40M1.02M-0.01M1.45M-0.04M6.29M1.22M0.90M0.01M-0.02M2.28M-0.06M0.00M-1.04M
Net income details
EBT (Quarter)
-18.70M-30.38M-23.62M-23.39M-24.26M-28.91M-25.81M-27.51M-27.45M-35.74M-33.29M-26.90M-23.23M-21.07M-10.58M-15.69M-17.21M-18.41M-13.66M-9.18M
Profit After Tax (Quarter)
-18.70M-30.38M-22.93M-23.39M-24.25M-28.91M-25.78M-27.54M-27.46M-35.75M-33.33M-26.93M-23.23M-21.07M-10.59M-14.88M-15.33M-18.71M-15.78M-9.78M
Income from Continuing Operations (Quarter)
-18.70M-30.38M-23.62M-23.39M-24.26M-28.91M-25.81M-27.51M-27.45M-35.74M-33.29M-26.90M-23.23M-21.07M-10.58M-15.69M-17.21M-18.41M-13.66M-9.18M
Consolidated Net Income (Quarter)
-18.70M-30.38M-23.62M-23.39M-24.26M-28.91M-25.81M-27.51M-27.45M-35.74M-33.29M-26.90M-23.23M-21.07M-10.58M-15.69M-17.21M-18.41M-13.66M-9.18M
Income towards Parent Company (Quarter)
-18.70M-30.38M-23.62M-23.39M-24.26M-28.91M-25.81M-27.51M-27.45M-35.74M-33.29M-26.90M-23.23M-21.07M-10.58M-15.69M-17.21M-18.41M-13.66M-9.18M
Net Income towards Common Stockholders (Quarter)
-18.70M-30.38M-22.93M-23.39M-24.26M-28.91M-25.81M-27.51M-27.45M-35.74M-33.29M-26.90M-23.23M-21.07M-10.58M-15.69M-17.21M-18.41M-13.66M-9.18M
Additional items
EPS (Basic) (Quarter)
-0.56-0.90-0.68-0.63-0.65-0.77-0.69-0.63-0.58-0.75-0.70-0.56-0.48-0.44-0.22-0.30-0.26-0.32-0.27-0.16
EPS (Weighted Average and Diluted) (Quarter)
-0.90-0.68-0.63-0.65-0.77-0.69-0.63-0.58-0.75-0.70-0.56-0.48-0.44-0.22-0.30-0.26-0.32-0.27-0.16
Shares Outstanding (Weighted Average) (Quarter)
33.63M33.68M33.75M34.56M37.32M37.42M37.42M38.93M47.58M47.71M47.71M47.78M48.09M48.15M48.21M48.57M58.25M58.50M58.75M58.83M
Shares Outstanding (Diluted Average) (Quarter)
33.67M33.75M34.56M37.32M37.42M37.52M38.93M47.58M47.71M47.83M47.78M48.09M48.15M48.21M48.57M58.25M58.50M58.50M58.83M
EBITDA (Quarter)
-18.80M-30.46M-23.70M-23.49M-24.35M-29.05M-26.18M-28.56M-28.93M-37.20M-35.02M-28.54M-24.46M-21.97M-11.27M-16.24M-17.61M-18.65M-13.79M-9.26M
Interest Expenses (Quarter)
0.00M0.00M
Shares Outstanding (Quarter)
1.49M32.32M1.49M35.80M1.49M35.99M36.37M1.21M47.64M47.80M47.91M48.08M48.11M48.33M0.19M58.10M58.40M58.72M58.79M63.46M